Release Date: 05/09/16 12:37 Summary: CORRECTION Valentia Investment Update-EVM.AX Price Sensitive: No Download Document 232.7KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%